Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Depreciation and Depletion: 2021-2024

Historic Depreciation and Depletion for Revolution Medicines (RVMD) over the last 4 years, with Dec 2024 value amounting to $6.2 million.

  • Revolution Medicines' Depreciation and Depletion rose 25.00% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 11.67%. This contributed to the annual value of $6.2 million for FY2024, which is 24.00% up from last year.
  • Latest data reveals that Revolution Medicines reported Depreciation and Depletion of $6.2 million as of FY2024, which was up 24.00% from $5.0 million recorded in FY2023.
  • Revolution Medicines' 5-year Depreciation and Depletion high stood at $6.2 million for FY2024, and its period low was $3.1 million during FY2021.
  • Moreover, its 3-year median value for Depreciation and Depletion was $5.0 million (2023), whereas its average is $5.1 million.
  • Data for Revolution Medicines' Depreciation and Depletion shows a peak YoY rose of 29.74% (in 2022) over the last 5 years.
  • Over the past 4 years, Revolution Medicines' Depreciation and Depletion (Yearly) stood at $3.1 million in 2021, then grew by 29.74% to $4.0 million in 2022, then increased by 25.00% to $5.0 million in 2023, then rose by 24.00% to $6.2 million in 2024.